Publications for Maria A. Sorbera

Touro College of Pharmacy (New York)
  • Sorbera, M. A., Friedman, M. L., & Cope, R. (2017). New and emerging evidence on the use of second-generation direct acting antivirals for the treatment of hepatitis C virus in renal impairment. Journal of Pharmacy Practice, 30(3), 359-365.

  • Del Bello, D., Cha, A., Sorbera, M. A., Bichoupan, K., Levine, C., Doyle, E., . . . Branch, A. D. (2016). Real-world sustained virologic response rates of sofosbuvir-containing regimens in patients coinfected with hepatitis C and HIV. Clinical Infectious Diseases, 62(12), 1497-1504. doi:10.1093/cid/ciw119

  • Sorbera, M. A., Chung, E., Ho, C. W., & Marzella, N. (2014). Ceftolozane/tazobactam: A new option in the treatment of complicated gram-negative infections. P & T, 39(12), 825, 828-832. PMCID: PMC4264669